SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 274 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $3,339,000 | -23.9% | 121,504 | -8.4% | 0.25% | -17.2% |
Q2 2019 | $4,388,000 | -15.9% | 132,607 | -11.0% | 0.30% | -8.7% |
Q1 2019 | $5,220,000 | +7.1% | 148,974 | +1.5% | 0.33% | -5.4% |
Q4 2018 | $4,875,000 | -40.9% | 146,739 | -10.5% | 0.35% | -23.0% |
Q3 2018 | $8,255,000 | -23.9% | 163,956 | -9.6% | 0.46% | -25.9% |
Q2 2018 | $10,850,000 | +18.4% | 181,283 | -9.4% | 0.62% | +21.1% |
Q1 2018 | $9,162,000 | -11.8% | 200,042 | -23.3% | 0.51% | +2.4% |
Q4 2017 | $10,388,000 | +48.8% | 260,676 | +49.3% | 0.50% | +74.6% |
Q3 2017 | $6,983,000 | – | 174,572 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |